RIGI and neoplasm: In addition to the generation of a cancer-specific immune response, exogenous mRNA helps to maintain an immune-friendly tumor microenvironment (TME) by triggering secretion of type I Interferon (IFN) and other inflammatory cytokines through activation of toll-like receptors (TLR) and retinoic acid-inducible gene I (RIG-I) [23].